Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Quebec to stop offering first shots of AstraZeneca vaccine

Thu, 13th May 2021 16:30

TORONTO, May 13 (Reuters) - The Canadian province of Quebec
will no longer offer first doses of the AstraZeneca
COVID-19 vaccine as of Thursday, but will offer second doses
using current supplies and future deliveries, the province's
health ministry said in a release.

Several provinces made similar announcements on Monday and
Tuesday, with most citing concerns about supply, though the
province of Ontario also indicated that it was concerned about
the risk of rare blood clots.
(Reporting by Allison Martell, Editing by Franklin Paul)

Related Shares

More News
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.